摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-O-demethyl-4β-[4-(6-methoxy-1,3-benzothiazole-2-yl)anilino]-4-desoxypodophyllotoxin | 1073610-36-2

中文名称
——
中文别名
——
英文名称
4'-O-demethyl-4β-[4-(6-methoxy-1,3-benzothiazole-2-yl)anilino]-4-desoxypodophyllotoxin
英文别名
4'-O-demethyl-4β-[4"-(6"-methoxy-1",3"-benzothiazole-2"-yl)anilino]-4-desoxy podophyllotoxin;(5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-5-[4-(6-methoxy-1,3-benzothiazol-2-yl)anilino]-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one
4'-O-demethyl-4β-[4-(6-methoxy-1,3-benzothiazole-2-yl)anilino]-4-desoxypodophyllotoxin化学式
CAS
1073610-36-2
化学式
C35H30N2O8S
mdl
——
分子量
638.698
InChiKey
UZPPDPKMAKBOQB-FPMZXNSHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    46
  • 可旋转键数:
    7
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    146
  • 氢给体数:
    2
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-(6-甲氧基-1,3-苯并噻唑-2-基)苯胺鬼臼毒素 以58%的产率得到4'-O-demethyl-4β-[4-(6-methoxy-1,3-benzothiazole-2-yl)anilino]-4-desoxypodophyllotoxin
    参考文献:
    名称:
    NOVEL 4BETA-AMINO PODOPHYLLOTOXIN CONGENERS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF
    摘要:
    本发明提供了一类新的4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]翠榆毒素类似物,其结构式如下所示(4)。其中R=H或CH3;R1=H、卤素、CH3;R2=H、卤素、OCH3。本发明还提供了一种制备新的4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]翠榆毒素类似物作为有效抗癌剂的方法。更具体地,它提供了一种制备翠榆毒素的4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]衍生物的方法。合成新翠榆毒素类似物作为抗癌剂的方法产生了翠榆毒素的新颖和立体选择性衍生物,其中这些类似物的合成关键步骤是通过对C-4β-碘中间体的直接亲核取代。4β-碘翠榆毒素与取代或未取代的4-(1,3-苯并噻唑-2-基)苯胺以立体选择性的方式反应,从而得到4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]翠榆毒素衍生物。
    公开号:
    US20080275248A1
点击查看最新优质反应信息

文献信息

  • An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity
    作者:Ahmed Kamal、B. Ashwini Kumar、Paidakula Suresh、Nagula Shankaraiah、M. Shiva Kumar
    DOI:10.1016/j.bmcl.2010.11.002
    日期:2011.1
    An efficient one-pot iodination methodology for the synthesis of benzothiazolo-4 beta-anilino-podophyllotoxin (5a-h) and benzothiazolo-4 beta-anilino-4-O-demethylepipodophyllotoxin (6a-h) congeners has been successfully developed by using zirconium tetrachloride/sodium iodide. Interestingly, this protocol demonstrates enhancement of stereoselectivity apart from the improvement in the yields in comparison to previous methods reported for such related podophyllotoxin derivatives. These compounds have been designed and synthesized using association strategy by coupling of 4 beta-podophyllotoxin and 4 beta-demethylepipodophyllotoxin with a variety of substituted aminoaryl benzothiazoles. Some of the representative compounds have been evaluated for their cytotoxicity against selected human cancer cell lines and DNA topoisomerase-II inhibition activity. (C) 2010 Elsevier Ltd. All rights reserved.
  • US7960418B2
    申请人:——
    公开号:US7960418B2
    公开(公告)日:2011-06-14
  • [EN] NOVEL 4ß-AMINO PODOPHYLLOTOXIN CONGENERS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF<br/>[FR] NOUVEAUX CONGÉNÈRES DE 4?-AMINO PODOPHYLLOTOXINE UTILISÉS COMME AGENTS ANTI-CANCEREUX POTENTIELS ET LEUR PROCÉDÉ DE PRÉPARATION
    申请人:COUNCIL SCIENT IND RES
    公开号:WO2008136018A2
    公开(公告)日:2008-11-13
    [EN] The present invention provides new class of 4ß-[4"-(1", 3"-benzothiazole-2"-yl) anilino] podophyllotoxin analogues having the structural formula (4) as follows. Where R = H or CH3; R2 = H, halogen, CH3 and R2 = H1 halogen, OCH3. The present invention also provides a process for the preparation of new 4ß- [4"-(1", 3"-benzothiazole-2"-yl) anilino] podophyllotoxin analogues as useful anticancer agents. More particularly, it provides a process for the preparation of 4ß- [4"-(1", 3"-benzothiazoIe-2"-yl) anilino] derivatives of podophyllotoxin. The process for the synthesis of new podophyllotoxin analogues as anticancer agents produces the novel and stereo-selective derivatives of the podophyllotoxin in good yields, where in the key step for the synthesis of these analogues is by direct nucleophilic substitution of C-4ß-iodo intermediates. The 4ß-iodopodophyllotoxin, which has been reacted with substituted or unsubstituted 4-(1,3-benzothiazole-2-yl) aniline in a stereo-selective manner to afford the 4ß-[4"-(1", 3"-benzothiazole-2"-yl) anilino] derivatives of podophyllotoxin.
    [FR] La présente invention concerne une nouvelle classe d'analogues de 4ß-[4'-(1', 3'-benzothiazole-2'-yl) anilino] podophyllotoxine représentée par la formule structurale (4) dans laquelle R = H ou CH3 ; R2 = H, halogène, CH3 et R2 = H1, halogène, OCH3. La présente invention concerne également un procédé pour la préparation de nouveaux analogues de 4ß- [4'-(1', 3'-benzothiazole-2'-yl) anilino] podophyllotoxine utilisés comme agents anti-cancéreux. L'invention concerne plus particulièrement un procédé pour la préparation de dérivés 4ß- [4'-(1', 3'-benzothiazoIe-2'-yl) anilino] de podophyllotoxine. Le procédé pour la synthèse de nouveaux analogues de podophyllotoxine utilisés comme agents anti-cancéreux produit les nouveaux dérivés stéréo-sélectifs de la podophyllotoxine avec de bons rendements, l'étape clé pour la synthèse de ces analogues étant la substitution nucléophile directe d'intermédiaires C-4ß-iodo. L'invention concerne également la 4ß-iodopodophyllotoxine, qui a été amenée à réagir avec une 4-(1,3-benzothiazole-2-yl) aniline substituée ou non substituée de façon stéréo-sélective pour produire les dérivés 4ß-[4'-(1', 3'-benzothiazole-2'-yl) anilino] de la podophyllotoxine.
  • NOVEL 4BETA-AMINO PODOPHYLLOTOXIN CONGENERS AS POTENTIAL ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF
    申请人:Ahmed Kamal
    公开号:US20080275248A1
    公开(公告)日:2008-11-06
    The present invention provides new class of 4β-[4″-(1″,3″-benzothiazole-2″-yl)anilino]podophyllotoxin analogues having the structural formula as follows (4). Where R═H or CH 3 ; R 1 ═H, halogen, CH 3 and R 2 ═H, halogen, OCH 3 . The present invention also provides a process for the preparation of new 4β-[4″-(1″, 3″-benzothiazole-2″-yl)anilino]podophyllotoxin analogues as useful anticancer agents. More particularly, it provides a process for the preparation of 4β-[4″-(1″,3″-benzothiazole-2″-yl)anilino] derivatives of podophyllotoxin. The process for the synthesis of new podophyllotoxin analogues as anticancer agents produces the novel and stereo-selective derivatives of the podophyllotoxin in good yields, where in the key step for the synthesis of these analogues is by direct nucleophilic substitution of C-4β-iodo intermediates. The 4β-iodopodophyllotoxin, which has been reacted with substituted or unsubstituted 4-(1,3-benzothiazole-2-yl)aniline in a stereo-selective manner to afford the 4β-[4″-(1″,3″-benzothiazole-2″-yl)anilino] derivatives of podophyllotoxin.
    本发明提供了一类新的4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]翠榆毒素类似物,其结构式如下所示(4)。其中R=H或CH3;R1=H、卤素、CH3;R2=H、卤素、OCH3。本发明还提供了一种制备新的4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]翠榆毒素类似物作为有效抗癌剂的方法。更具体地,它提供了一种制备翠榆毒素的4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]衍生物的方法。合成新翠榆毒素类似物作为抗癌剂的方法产生了翠榆毒素的新颖和立体选择性衍生物,其中这些类似物的合成关键步骤是通过对C-4β-碘中间体的直接亲核取代。4β-碘翠榆毒素与取代或未取代的4-(1,3-苯并噻唑-2-基)苯胺以立体选择性的方式反应,从而得到4β-[4″-(1″,3″-苯并噻唑-2″-基)苯胺基]翠榆毒素衍生物。
查看更多

同类化合物

鬼臼脂毒酮 鬼臼毒素-4-O-葡萄糖苷 鬼臼毒素 鬼臼毒素 苦鬼臼毒素 脱氧鬼臼毒素 磷酸依托泊甙 盾叶鬼臼素 澳白木脂素2 澳白木脂素1 替尼泊苷 托尼依托泊苷 去氧鬼臼毒素 克立米星C 他氟泊苷 丙氨酸,N-(羧基甲基)-(9CI) alpha-盾叶鬼臼素 alpha-依托泊苷 [(5R,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-8-氧代-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-5-基]丁酸酯 TOP-53二盐酸盐 NK-611盐酸盐 5,8,8a,9-四氢-9-羟基-5-(3,4,5-三甲氧基苯基)-(5R,5aR,8aR,9S)-呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5aH)-酮 4’-去甲鬼臼毒素 4’-去甲基表鬼臼毒素-Β-D-葡萄糖甙 4-{[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]氨基甲酰}苯基乙酸酯 4,6-O-苄叉-Β-D-葡萄糖甙鬼臼毒素 4'-去甲基表鬼臼毒素 4'-O-脱甲基-4-((4'-(1'-苯甲基哌啶基))氨基)-4-脱氧鬼臼毒 4 ’-去甲去氧鬼臼毒素 3-羟基-4H-吡喃-4-酮 3-氨基-N-[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]苯酰胺 2’-O-没食子酰基金丝桃甙 2(3H)-硫代酰苯,3-乙基二氢-3-(1-甲基乙基)-(9CI) 2'-氯依托泊苷 1-羟基-17-氧杂五环[6.6.5.0~2,7~.0~9,14~.0~15,19~]十九碳-2,4,6,9,11,13-六烯-16,18-二酮(non-preferredname) (8aR,9S)-9-[[(2R)-7,8-二羟基-2-(2-噻吩基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5S,5aS,8aR,9R)-5-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基-苯基)-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-8-酮 (5S,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-5-(4-羟基苯基)硫烷基-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二噁唑-8-酮 (5R,5aR,8aS,9S)-9-[(4-氨基苯基)氨基]-5-(4-羟基-3,5-二甲氧苯基)-5,8,8a,9-四氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-6(5aH)-酮盐酸(1:1) (5R,5aR,8aR,9R)-9-羟基-10-甲氧基-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(4-甲氧基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(2-羟基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-8-羰基-9-(3,4,5-三甲氧苯基)-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基乙酸酯 (5R,5aR,8aR,9R)-5-(4-乙氧基-3,5-二甲氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-5-(3,5-二甲氧基-4-丙氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R)-5,8,8ab,9-四氢-5b-(3,4,5-三甲氧基苯基)呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5abH),9-二酮 (5-氯吡啶-3-基)丙酸甲酯 (3aS,4S,9R,9aR)-4-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基苯基)-6,7-二甲氧基-3a,4,9,9a-四氢-3H-萘并[3,2-c]呋喃-1-酮 (3aR,4S,9R,9aR)-4,6,7-三羟基-9-(4-羟基-3,5-二甲氧苯基)-3a,4,9,9a-四氢萘并[2,3-c]呋喃-1(3H)-酮 (1R,3aS,4R,6aR)-4-(1,3-苯并二氧戊环-4-基)-1-(1,3-苯并二氧戊环-5-基)-3,3a,4,6a-四氢-1H-呋喃并[3,4-c]呋喃-6-酮